| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $4.4M | +66.0% |
| SG&A Expense | $4.6M | -25.4% |
| Operating Income | -$8.9M | -2.2% |
| Pre-tax Income | -$8.6M | +1.6% |
| Income Tax | $90K | +193.8% |
| Net Income | -$1.0M | +91.0% |
| EPS (Basic) | -$0.02 | +92.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.8M | +166.5% |
| Short-term Investments | $4.8M | — |
| Current Assets | $20.9M | -26.9% |
| Total Assets | $25.9M | -24.4% |
| Current Liabilities | $13.6M | +23.3% |
| Total Liabilities | $49.9M | +2.7% |
| Stockholders' Equity | -$32.2M | +2.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.8M | -20.2% |
| Capital Expenditures | $50K | -77.7% |
| Investing Cash Flow | $10.8M | +189.8% |
| Financing Cash Flow | $5.0M | -81.5% |
| Free Cash Flow | -$19.8M | -18.9% |